CHIN-HSIAO TSENG2020-06-012020-06-0120160959-8049https://www.scopus.com/inward/record.uri?eid=2-s2.0-84964253538&doi=10.1016%2fj.ejca.2016.03.064&partnerID=40&md5=9364fb15e2a48e7a1961333dcf816b3dhttps://scholars.lib.ntu.edu.tw/handle/123456789/496067[SDGs]SDG3metformin; metformin; cancer epidemiology; cancer incidence; cancer prevention; cancer risk; diabetic patient; dose response; human; kidney cancer; Letter; non insulin dependent diabetes mellitus; priority journal; selection bias; chin; kidney tumor; non insulin dependent diabetes mellitus; risk; Chin; Diabetes Mellitus, Type 2; Humans; Kidney Neoplasms; Metformin; RiskResponse to Letter to the Editor on comments on Use of metformin and risk of kidney cancer in patients with type 2 diabetes Chin-Hsiao Tseng, Eur J Cancer, 2016, No. 52p. 19-25letter10.1016/j.ejca.2016.03.064271331982-s2.0-84964253538